Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Sublocade 1Standard of Care 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Opioid-Related Disorders × Clear all
NCT04060654 2025-03-25

SUBLOCADE Rapid Initiation Extension Study

Indivior Inc.

Phase 4 Completed
17 enrolled 12 charts
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04982627 2024-07-03

BNICHAT

Center for Progressive Recovery, LLC

Phase NA Completed
4 enrolled
Lymphoid

Criminal Behavior, Lymphoma, Follicular, Opioid-Related Disorders

NCT02611752 2019-11-14

A Multiple Dose Opioid Challenge Study

Braeburn Pharmaceuticals

Phase 2 Completed
47 enrolled 18 charts
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡